180 related articles for article (PubMed ID: 23756374)
1. Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria.
Lessells RJ; Mutevedzi PC; Iwuji CC; Newell ML
J Acquir Immune Defic Syndr; 2014 Jan; 65(1):e17-24. PubMed ID: 23756374
[TBL] [Abstract][Full Text] [Related]
2. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
McGrath N; Lessells RJ; Newell ML
HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
[TBL] [Abstract][Full Text] [Related]
3. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
[TBL] [Abstract][Full Text] [Related]
4. Disengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa.
Mutevedzi PC; Lessells RJ; Newell ML
Trop Med Int Health; 2013 Aug; 18(8):934-41. PubMed ID: 23731253
[TBL] [Abstract][Full Text] [Related]
5. Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
Mutevedzi PC; Lessells RJ; Rodger AJ; Newell ML
PLoS One; 2011; 6(7):e21795. PubMed ID: 21747959
[TBL] [Abstract][Full Text] [Related]
6. Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
Bassett IV; Regan S; Chetty S; Giddy J; Uhler LM; Holst H; Ross D; Katz JN; Walensky RP; Freedberg KA; Losina E
AIDS; 2010 Jan; 24 Suppl 1(Suppl 1):S37-44. PubMed ID: 20023438
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
[TBL] [Abstract][Full Text] [Related]
8. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
10. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
[TBL] [Abstract][Full Text] [Related]
11. Do HIV treatment eligibility expansions crowd out the sickest? Evidence from rural South Africa.
Kluberg SA; Fox MP; LaValley M; Pillay D; Bärnighausen T; Bor J
Trop Med Int Health; 2018 Sep; 23(9):968-979. PubMed ID: 29947442
[TBL] [Abstract][Full Text] [Related]
12. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
[TBL] [Abstract][Full Text] [Related]
13. Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis.
Osler M; Cornell M; Ford N; Hilderbrand K; Goemaere E; Boulle A
J Int AIDS Soc; 2020 Jun; 23 Suppl 2(Suppl 2):e25530. PubMed ID: 32589367
[TBL] [Abstract][Full Text] [Related]
14. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
Kiertiburanakul S; Boettiger D; Lee MP; Omar SF; Tanuma J; Ng OT; Durier N; Phanuphak P; Ditangco R; Chaiwarith R; Kantipong P; Lee CK; Mustafa M; Saphonn V; Ratanasuwan W; Merati TP; Kumarasamy N; Wong WW; Zhang F; Pham TT; Pujari S; Choi JY; Yunihastuti E; Sungkanuparph S; ;
J Int AIDS Soc; 2014; 17(1):18804. PubMed ID: 24598459
[TBL] [Abstract][Full Text] [Related]
15. Loss to care and death before antiretroviral therapy in Durban, South Africa.
Bassett IV; Wang B; Chetty S; Mazibuko M; Bearnot B; Giddy J; Lu Z; Losina E; Walensky RP; Freedberg KA
J Acquir Immune Defic Syndr; 2009 Jun; 51(2):135-9. PubMed ID: 19504725
[TBL] [Abstract][Full Text] [Related]
16. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
[TBL] [Abstract][Full Text] [Related]
17. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Siegfried N; Uthman OA; Rutherford GW
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
[TBL] [Abstract][Full Text] [Related]
18. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.
Kaplan R; Hermans S; Caldwell J; Jennings K; Bekker LG; Wood R
BMC Infect Dis; 2018 Jul; 18(1):356. PubMed ID: 30064368
[TBL] [Abstract][Full Text] [Related]
19. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
[TBL] [Abstract][Full Text] [Related]
20. Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa.
Lessells RJ; Mutevedzi PC; Cooke GS; Newell ML
J Acquir Immune Defic Syndr; 2011 Mar; 56(3):e79-86. PubMed ID: 21157360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
